% alzhub.org library filter
% Source: https://alzhub.org/research?author=Lu+M&access=free
% 14 entries, in the order the page lists them. Built from alzhub.org's own records.
% 0 entries have no readable author in the source record and carry no author field.

@article{zimmer2025-40063015,
  author  = {Zimmer, J. A. and Ardayfio, P. and Wang, H. and Khanna, R. and Evans, C. D. and Lu, M. and Sparks, J. and Andersen, S. and Lauzon, S. and Nery, E. S. M. and others},
  title   = {{Amyloid-Related Imaging Abnormalities With Donanemab in Early Symptomatic Alzheimer Disease: Secondary Analysis of the TRAILBLAZER-ALZ and ALZ 2 Randomized Clinical Trials}},
  journal = {JAMA Neurology},
  year    = {2025},
  doi     = {10.1001/jamaneurol.2025.0065},
  pmid    = {40063015},
  url     = {https://doi.org/10.1001/jamaneurol.2025.0065}
}

@article{pontecorvo2022-36251300,
  author  = {Pontecorvo, M. J. and Lu, M. and Burnham, S. C. and Schade, A. E. and Dage, J. L. and Shcherbinin, S. and Collins, E. C. and Sims, JR. and others},
  title   = {{Association of Donanemab Treatment With Exploratory Plasma Biomarkers in Early Symptomatic Alzheimer Disease: A Secondary Analysis of the TRAILBLAZER-ALZ Randomized Clinical Trial}},
  journal = {JAMA neurology},
  year    = {2022},
  doi     = {10.1001/jamaneurol.2022.3392},
  pmid    = {36251300},
  url     = {https://doi.org/10.1001/jamaneurol.2022.3392}
}

@article{lu2025-41082199,
  author  = {Lu, M. and Kim, M. J. and Collins, E. C. and Shcherbinin, S. and Ellinwood, A. K. and Yokoi, Y. and Brooks, D. A. and Hansson, O. and others},
  title   = {{Posttreatment Amyloid Levels and Clinical Outcomes Following Donanemab for Early Symptomatic Alzheimer Disease: A Secondary Analysis of the TRAILBLAZER-ALZ 2 Randomized Clinical Trial}},
  journal = {JAMA neurology},
  year    = {2025},
  doi     = {10.1001/jamaneurol.2025.3869},
  pmid    = {41082199},
  url     = {https://doi.org/10.1001/jamaneurol.2025.3869}
}

@article{shcherbinin2022-36094645,
  author  = {Shcherbinin, S. and Evans, C. D. and Lu, M. and Andersen, S. W. and Pontecorvo, M. J. and Willis, B. A. and Gueorguieva, I. and Hauck, P. M. and others},
  title   = {{Association of Amyloid Reduction After Donanemab Treatment With Tau Pathology and Clinical Outcomes: The TRAILBLAZER-ALZ Randomized Clinical Trial}},
  journal = {JAMA neurology},
  year    = {2022},
  doi     = {10.1001/jamaneurol.2022.2793},
  pmid    = {36094645},
  url     = {https://doi.org/10.1001/jamaneurol.2022.2793}
}

@article{sims2023-37459141,
  author  = {Sims, JR. and Zimmer, J. A. and Evans, C. D. and Lu, M. and Ardayfio, P. and Sparks, J. and Wessels, A. M. and Shcherbinin, S. and others},
  title   = {{Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical Trial}},
  journal = {JAMA},
  year    = {2023},
  doi     = {10.1001/jama.2023.13239},
  pmid    = {37459141},
  url     = {https://doi.org/10.1001/jama.2023.13239}
}

@article{pontecorvo2019-31009046,
  author  = {Pontecorvo, M. J. and Devous, M. D. and Kennedy, I. and Navitsky, M. and Lu, M. and Galante, N. and Salloway, S. and Doraiswamy, P. M. and others},
  title   = {{A multicentre longitudinal study of flortaucipir (18F) in normal ageing, mild cognitive impairment and Alzheimer's disease dementia}},
  journal = {Brain : a journal of neurology},
  year    = {2019},
  doi     = {10.1093/brain/awz090},
  pmid    = {31009046},
  url     = {https://doi.org/10.1093/brain/awz090}
}

@article{fleisher2020-32338734,
  author  = {Fleisher, A. S. and Pontecorvo, M. J. and Devous, M. D. and Lu, M. and Arora, A. K. and Truocchio, S. P. and Aldea, P. and Flitter, M. and others},
  title   = {{Positron Emission Tomography Imaging With [18F]flortaucipir and Postmortem Assessment of Alzheimer Disease Neuropathologic Changes}},
  journal = {JAMA neurology},
  year    = {2020},
  doi     = {10.1001/jamaneurol.2020.0528},
  pmid    = {32338734},
  url     = {https://doi.org/10.1001/jamaneurol.2020.0528}
}

@article{atri2026-42128444,
  author  = {Atri, A. and Apostolova, L. G. and Iwata, A. and Wessels, A. M. and Atkins, A. and Lu, M. and Ye, W. and Ryan, S. and Doty, E. G.},
  title   = {{Clinical Meaningfulness of Donanemab in Early Symptomatic Alzheimer Disease: Data From the Randomized Phase 3 TRAILBLAZER-ALZ 2 Trial}},
  journal = {Neurology: Clinical Practice},
  year    = {2026},
  doi     = {10.1212/CPJ.0000000000200621},
  pmid    = {42128444},
  url     = {https://doi.org/10.1212/CPJ.0000000000200621}
}

@article{southekal2018-29191858,
  author  = {Southekal, S. and Devous, M. D. and Kennedy, I. and Navitsky, M. and Lu, M. and Joshi, A. D. and Pontecorvo, M. J. and Mintun, M. A.},
  title   = {{Flortaucipir F 18 Quantitation Using Parametric Estimation of Reference Signal Intensity}},
  journal = {Journal of nuclear medicine : official publication, Society of Nuclear Medicine},
  year    = {2018},
  doi     = {10.2967/jnumed.117.200006},
  pmid    = {29191858},
  url     = {https://doi.org/10.2967/jnumed.117.200006}
}

@article{collins2026-42565262,
  author  = {Collins, E. C. and Lu, M. and Beck, R. and Hendrix, J. and Hodsdon, M. E. and Hansson, O.},
  title   = {{Plasma P-tau217 for detecting amyloid clearance after donanemab in Alzheimer's disease}},
  journal = {Alzheimer's \& Dementia},
  year    = {2026},
  doi     = {10.1002/alz.71740},
  pmid    = {42565262},
  url     = {https://doi.org/10.1002/alz.71740}
}

@article{devous2018-29284675,
  author  = {Devous, M. D. and Joshi, A. D. and Navitsky, M. and Southekal, S. and Pontecorvo, M. J. and Shen, H. and Lu, M. and Shankle, W. R. and others},
  title   = {{Test-Retest Reproducibility for the Tau PET Imaging Agent Flortaucipir F 18}},
  journal = {Journal of nuclear medicine : official publication, Society of Nuclear Medicine},
  year    = {2018},
  doi     = {10.2967/jnumed.117.200691},
  pmid    = {29284675},
  url     = {https://doi.org/10.2967/jnumed.117.200691}
}

@article{abel2025-39836199,
  author  = {Abel, A. and Chambers, A. and Fill, J. and Reiske, H. and Lu, M. and Morris, A. and Faya, P. and Beck, R. C. and others},
  title   = {{Analytical Validation and Performance of a Blood-Based P-tau217 Diagnostic Test for Alzheimer Disease}},
  journal = {The journal of applied laboratory medicine},
  year    = {2025},
  doi     = {10.1093/jalm/jfae155},
  pmid    = {39836199},
  url     = {https://doi.org/10.1093/jalm/jfae155}
}

@article{joshi2015-26338898,
  author  = {Joshi, A. D. and Pontecorvo, M. J. and Lu, M. and Skovronsky, D. M. and Mintun, M. A. and Devous, M. D.},
  title   = {{A Semiautomated Method for Quantification of F 18 Florbetapir PET Images}},
  journal = {Journal of nuclear medicine : official publication, Society of Nuclear Medicine},
  year    = {2015},
  doi     = {10.2967/jnumed.114.153494},
  pmid    = {26338898},
  url     = {https://doi.org/10.2967/jnumed.114.153494}
}

@article{lu2011-21252229,
  author  = {Lu, M. and Zheng, L. and Han, B. and Wang, L. and Wang, P. and Liu, H. and Sun, X.},
  title   = {{REST regulates DYRK1A transcription in a negative feedback loop}},
  journal = {The Journal of biological chemistry},
  year    = {2011},
  doi     = {10.1074/jbc.m110.174540},
  pmid    = {21252229},
  url     = {https://doi.org/10.1074/jbc.m110.174540}
}